Last quarter (Q2 2023), RVL Pharmaceuticals's total revenue was $8.26M, a decrease of -2.25% from the same quarter last year. In Q2, RVL Pharmaceuticals's net income was $-23.89M. See RVL Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 36.92M	$ 49.72M	$ 17.50M	$ 27.76M	$ 240.03M	$ 263.70M
Cost of Revenue	$ 4.21M	$ -9.46M	$ -3.62M	$ 3.29M	$ 111.63M	$ 140.08M
Gross Profit	$ 27.59M	$ 40.27M	$ 13.88M	$ 24.47M	$ 128.40M	$ 123.62M
Operating Expense	$ 42.13M	$ -99.25M	$ -102.27M	$ 86.21M	$ 125.35M	$ 117.94M
Operating Income	$ -52.23M	$ -56.13M	$ -88.39M	$ -61.74M	$ 3.05M	$ 5.68M
Net Non Operating Interest Income Expense	$ 5.13M	$ 3.15M	$ -4.37M	$ -4.09M	$ -18.21M	$ -20.79M
Other Income Expense	$ -8.16M	$ -1.27M	$ -14.29M	$ -28.96M	$ -282.86M	$ -103.56M
Pretax Income	$ -68.54M	$ -51.71M	$ -82.53M	$ -94.80M	$ -298.02M	$ -118.66M
Tax Provision	$ -277.00K	$ -20.00K	$ 315.00K	$ -5.78M	$ -27.12M	$ -8.98M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -68.27M	$ -51.69M	$ -64.92M	$ -79.59M	$ -270.90M	$ -109.68M
Basic EPS	$ -0.72	$ -0.58	$ -0.96	$ -1.31	$ -5.17	$ -2.42
Diluted EPS	$ -0.72	$ -0.58	$ -1.01	$ -1.31	$ -5.17	$ -2.42
Basic Average Shares	$ 381.25M	$ 89.80M	$ 67.63M	$ 60.65M	$ 52.37M	$ 45.28M
Diluted Average Shares	$ 381.25M	$ 89.80M	$ 67.35M	$ 60.65M	$ 52.37M	$ 45.28M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 46.34M	$ -108.71M	$ -105.89M	$ 89.50M	$ 236.98M	$ 258.02M
Net Income From Continuing And Discontinued Operation	$ -68.27M	$ -51.69M	$ -64.92M	$ -79.59M	$ -270.90M	$ -109.68M
Normalized Income	$ -35.77M	-	-	$ -61.88M	$ -12.97M	$ -13.35M
Interest Expense	$ 1.13M	-	-	$ 4.09M	$ 18.21M	$ 20.79M
EBIT	$ -72.78M	$ -53.49M	$ -88.02M	$ -90.70M	$ -279.81M	$ -97.87M
EBITDA	$ -72.40M	$ -50.05M	$ -78.23M	$ -69.67M	$ -222.80M	$ -16.30M

Currency in USD

RVL Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing